Skip to content
Oncology Research Hub

New Jersey

Cancer clinical trials in New Jersey

409 cancer studies are recruiting participants at sites in 59 cities across New Jersey as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every New Jersey city with a recruiting study

By research area: Breast Cancer (127), Lung Cancer (119), Lymphoma (76), Prostate Cancer (42), Pancreatic Cancer (25), Melanoma (20).

Middletown (128), Basking Ridge (127), Montvale (125), Hackensack (101), New Brunswick (95), East Brunswick (48), Morristown (43), Camden (23), Summit (22), Long Branch (19), Newark (17), Voorhees Township (16), Livingston (15), Paramus (15), Sewell (15), Englewood (14), Somerville (14), Toms River (14), Jersey City (13), Cherry Hill (12), Elizabeth (11), Neptune City (11), Paterson (11), Lakewood (10), Belleville (9), Moorestown (9), Hamilton (8), Florham Park (7), Teaneck (7), Pennington (6), Pompton (6), Flemington (5), Hackettstown (5), Mullica Hill (5), Newton (5), Ridgewood (5), Manahawkin (4), Red Bank (4), Brick (3), East Hanover (3), Piscataway (3), Plainsboro (3), Princeton (3), Cape May Court House (2), Edison (2), Egg Harbor (2), Freehold (2), Holmdel (2), Vineland (2), Clifton (1), Millburn (1), North Bergen (1), Nutley (1), Old Bridge (1), Perth Amboy (1), Saddle Brook (1), Somerset (1), Totowa (1), Whippany (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in New Jersey

Basic details from each study's public record (the 12 most recently updated of 409). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    New Brunswick
    Registry record
    NCT06686394 · updated
  2. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    LeonaBio
    Recruiting in
    New Brunswick
    Registry record
    NCT05696626 · updated
  3. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Basking Ridge · Hackensack · Middletown · and 2 more U.S. locations
    Registry record
    NCT07488676 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in New Jersey on ClinicalTrials.gov.

Lung cancer: recently updated in New Jersey

  1. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Recruiting in
    Neptune City
    Registry record
    NCT02468024 · updated
  2. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    East Brunswick
    Registry record
    NCT07277413 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in New Jersey on ClinicalTrials.gov.

Prostate cancer: recently updated in New Jersey

  1. Radiation Therapy Approaches for People With Prostate Cancer

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Basking Ridge · Middletown · Montvale
    Registry record
    NCT07751159 · updated
  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Camden · New Brunswick · Somerville · and 2 more U.S. locations
    Registry record
    NCT04423211 · updated
  3. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Morristown
    Registry record
    NCT06136624 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in New Jersey on ClinicalTrials.gov.

Melanoma: recently updated in New Jersey

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Hackensack · Hackettstown · Long Branch · and 7 more U.S. locations
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in New Jersey on ClinicalTrials.gov.

Lymphoma: recently updated in New Jersey

  1. Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Basking Ridge · Middletown
    Registry record
    NCT02974647 · updated
  2. A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Belleville
    Registry record
    NCT06717347 · updated
  3. A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Morristown · Paramus
    Registry record
    NCT06890884 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in New Jersey on ClinicalTrials.gov.

Ask about studies in New Jersey

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call